vimarsana.com

Latest Breaking News On - Ulf teichgr - Page 4 : vimarsana.com

Well Begun AND Half Done! - SIRONA Randomized Trial Achieves fifty percent enrollment

JENA, Germany, Feb. 9, 2022 /PRNewswire/ Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status

Germany
Bad-krozingen
Baden-wüberg
Austria
Thomas-zeller
Herzzentrum-freiburg
Ulf-teichgr
Marianne-brodmann
University-of-graz
Jena-university-hospital
Concept-medical-inc
Nanolute-technology

SIRONA - The world's first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly

SIRONA - The world s first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly SIRONA Randomized Control Trial (RCT) which compares head-to-head, SIROlimus versus Paclitaxel Drug-Eluting Balloo N Angioplasty in femoropopliteal arterial diseases (SIRONA). SIRONA is the world s first RCT investigating the use of Sirolimus drug coated balloon (DCB) (MagicTouch PTA - Concept Medical) V/S Paclitaxel DCB for the treatment of femoropopliteal artery disease. SIRONA is an Investigator-Initiated and driven, prospective, multi-center, corelab adjudicated randomized trial to compare and evaluate the safety and efficacy of Sirolimus Coated balloon versus Paclitaxel Coated Balloon (CE certified devices) in the treatment of stenosed or occluded lesions in the superficial femoral artery (SFA), and/or popliteal artery (P1) in Peripheral Arterial Disease (PAD) patients with Rutherford classification 2 to 4. The study wi

Germany
Austria
United-states
America
Kostenloser-wertpapierhandel
Ulf-teichgr
Jena-university-hospital
Prnewswire-concept-medical-inc
Medical-inc
Control-trial
Paclitaxel-drug-eluting
Sirolimus-coated

SIRONA - The world's first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly

SIRONA - The world's first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Germany
Austria
United-states
America
Ulf-teichgr
Jena-university-hospital
Sirolimus-coated
Paclitaxel-coated-balloon
Peripheral-arterial-disease
Principal-investigator
North-america
Critical-limb-ischemia
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.